2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014

03-Dec-2007Covance and Care Partner on Rwanda Early Childhood Development Initiative Print
27-Nov-2007Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRT's Centralized Cardiac Safety Services Print
24-Oct-2007Covance Reports 3Q07 Earnings of $0.69 Per Share Print
27-Sep-2007Covance Elects Dr. Gary E. Costley to Board of Directors Print
17-Sep-2007Covance Enhances IVR Services with State-of-the-Art Interactive Web Response (IWR) Powered by Clarix Print
28-Aug-2007Covance Opens Nutritional Chemistry Laboratory in Singapore to Service Asia-based Clients Print
25-Jul-2007Covance Reports 2Q07 Earnings of $0.64 Per Share Print
24-May-2007Covance Supports Growth in Vaccine Market, Expands Preclinical Research Services with New Dedicated ABSL-2 Vivarium Print
15-May-2007Covance Completes Microdose Study Under expIND Pathway Print
30-Apr-2007Covance Reports 1Q07 Earnings of $0.60 Per Share Print
09-Apr-2007Covance Enhances Custom Antibody Production Capabilities With State-Of-The-Art Antibody Purification System Print
27-Mar-2007Covance Announces Biomarker Expert Team Dedicated to Development, Validation, Testing of Biomarkers Print
22-Feb-2007Covance Board Authorizes Increased Stock Buyback Print
31-Jan-2007Covance Expands, Consolidates Research Clinic In Austin, TX Print
24-Jan-2007Covance Reports 4Q EPS of $0.59 & Sixth Consecutive Year of 25% EPS Growth Print
24-Jan-2007Covance to Expand Presence in China with New Shanghai Central Laboratory and Relocate Beijing Office to Support Global, Regional Clinical Trials Print
22-Jan-2007Covance Becomes Exclusive Provider of Neuroscience Gold Standard Antibodies 6E10 and 4G8 for Alzheimer's Disease, 3F4 for Prion Diseases Print
11-Jan-2007Covance to Ring The Closing Bell at NYSE on January 11 Print